Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The biological role of deltex family protein 3 (DTX3), a putative E3 ubiquitin ligase, in cancer is largely unknown.
• Mutant p53 proteins are frequently found in ovarian carcinomas and contribute to tumorigenesis.

Purpose of the Study:

• To investigate the role of DTX3 in ovarian cancer.
• To elucidate the mechanism by which DTX3 influences mutant p53 activity and ovarian tumorigenesis.

Main Methods:

• Identification of DTX3 as a mutant p53-interacting protein.
• Assessment of DTX3's effect on mutant p53 ubiquitination, stabilization, and target gene activation.
• In vitro and in vivo assays to evaluate the impact of DTX3 on ovarian cancer cell proliferation, invasion, and tumor growth.
• Analysis of DTX3 expression and its correlation with prognosis in ovarian carcinoma patient cohorts.

Main Results:

• DTX3 directly interacts with and stabilizes mutant p53 by disrupting the MDM2-mutant p53 complex.
• DTX3 overexpression enhances ovarian cancer cell proliferation, invasion, and tumor growth in vivo, effects dependent on mutant p53.
• DTX3 expression positively correlates with mutant p53 target gene expression and is associated with unfavorable patient prognosis.
• DTX3 amplification and overexpression are observed in ovarian carcinomas.

Conclusions:

• DTX3 functions as an oncoprotein in ovarian cancer by enhancing mutant p53 activity and stability.
• DTX3 represents a potential therapeutic target for ovarian cancer, particularly in tumors harboring mutant p53.